Literature DB >> 3519548

Ontogenic and functional implications of the differential expression of HLA-DQ antigens on leukemic cells.

C Navarrete, N Fernandez, M C Alonso, H Festenstein.   

Abstract

We have examined the HLA class II antigenic profiles on different types of leukemic cells and have attempted to relate these findings to the normal differentiation pathways of the cells from which they have arisen. Monoclonal antibodies reacting with the different HLA class II determinants, HLA-DR, DRw52(MT), and DQ, were used to study the expression of these antigens on Epstein-Barr virus transformed cell lines, chronic lymphocytic leukemic cells, acute lymphoblastic leukemic blasts, acute myeloblastic leukemic blasts, and established leukemic cell lines by indirect immunofluorescence binding and immunoprecipitations. The results showed that whereas the HLA-DR and HLA-DRw52(MT2) antigens are normally expressed on the majority of the cells tested, there is a different expression of the HLA-DQ antigens on acute leukemic blasts, chronic lymphocytic leukemic cells, and leukemic cell lines indicating that the DQ molecules may be differentiation antigens preferentially expressed on mature cells. Furthermore, when the pre-B cell leukemic line NALM 6 was induced to differentiate with phorbol ester (TPA), normal expression of the HLA-DQ antigen was obtained after 5 days of culture. The absence of HLA-DQ antigens from the acute leukemic blasts suggests that these immature cells "froze" in the early stages of cell differentiation. We discuss these findings in relation to the role of these HLA class II antigens in cell differentiation and the immune response.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3519548     DOI: 10.1016/0198-8859(86)90035-2

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  3 in total

1.  A novel HLA class II molecule.

Authors:  N Fernandez; M O Labeta; H Festenstein
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

2.  Variant sublines of the human B-lymphoma cells Namalwa are at different stages of differentiation.

Authors:  K Guy; P G Middleton; C M Steel
Journal:  Immunology       Date:  1987-07       Impact factor: 7.397

3.  Expression of MHC class II, interleukin 2 receptor and CD45 antigens on tumour-associated T lymphocytes in colonic carcinoma.

Authors:  M N Norazmi; A W Hohmann; J M Skinner; J Bradley
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.